PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Emergency Medicine, Department of Microbiology and Physiological Systems, Clinical Director of the Center for Microbiome Research, University of Massachusetts Medical School, UMass Memorial Medical Group, Worcester, MA, USA. johnP.Haran@umassmemorial.org.\', \'Hope Clinical Trials, Miami, FL, USA.\', \'Kaleido Biosciences, Inc, Lexington, MA, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1186/s13063-021-05157-0
?:doi
?:hasPublicationType
?:journal
  • Trials
is ?:pmid of
?:pmid
?:pmid
  • 33810796
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.291
?:rankingScore_hIndex
  • 57
is ?:relation_isRelatedTo_publication of
?:title
  • Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33810796>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33810796>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all